North America:
The North America artificial pancreas market is experiencing robust growth due to the rising prevalence of type 1 diabetes and advancements in diabetes management technology. The United States, being a major market, benefits from a high level of healthcare spending, significant research and development investments, and a strong focus on innovative diabetes care...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian